Journal
Blood Advances
Publication Date
3-25-2025
Volume
9
Issue
6
First Page
1247
Last Page
1260
Document Type
Open Access Publication
DOI
10.1182/bloodadvances.2024014219
Rights and Permissions
Siegal DM, Tseng EK, Schünemann HJ, Angchaisuksiri P, Cuker A, Dane K, DeSancho MT, Diuguid D, Griffin DO, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo KM, Terrell DR, Akl EA, Al Jabiri R, Al Jabiri Y, Barbara AM, Bognanni A, Akl IB, Boulos M, Brignardello-Petersen R, Chan M, Charide R, Colunga-Lozano LE, Dearness K, Darzi AJ, Hussein H, Karam SG, Kolb P, Mansour R, Morgano GP, Morsi RZ, Muti-Schünemann G, Nadim MK, Noori A, Philip BA, Piggott T, Qiu Y, Benitez YR, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Nieuwlaat R. American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary. Blood Adv. 2025 Mar 25;9(6):1247-1260. doi: 10.1182/bloodadvances.2024014219 © 2025 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
Recommended Citation
Siegal, Deborah M; Sanfilippo, Kristen M; Al Jabiri, Yazan; and et al., "American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: Executive summary." Blood Advances. 9, 6. 1247 - 1260. (2025).
https://digitalcommons.wustl.edu/oa_4/6373
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
